Medigus Ltd.

Symbol: MDGS

NASDAQ

2.745

USD

Market price today

  • -0.2062

    P/E Ratio

  • -0.0022

    PEG Ratio

  • 4.67M

    MRK Cap

  • 0.00%

    DIV Yield

Medigus Ltd. (MDGS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.15%

Operating Profit Margin

-0.09%

Net Profit Margin

-0.13%

Return on Assets

-0.22%

Return on Equity

-0.53%

Return on Capital Employed

-0.24%

Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Mr. Liron Carmel
Full-time employees:77
City:Tel Aviv
Address:Building B
IPO:2015-08-05
CIK:0001618500

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

General Outlook

When we look at how much money they make before expenses, they keep 0.150% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.086%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.135%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.218% return, is a testament to Medigus Ltd.'s adeptness in optimizing resource deployment. Medigus Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.527%. Furthermore, the proficiency of Medigus Ltd. in capital utilization is underscored by a remarkable -0.240% return on capital employed.

Stock Prices

Medigus Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.64, while its low point bottomed out at $1.6. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Medigus Ltd.'s stock market.

Liquidity Ratios

Analyzing MDGS liquidity ratios reveals its financial health of the firm. The current ratio of 129.72% gauges short-term asset coverage for liabilities. The quick ratio (122.13%) assesses immediate liquidity, while the cash ratio (34.45%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio129.72%
Quick Ratio122.13%
Cash Ratio34.45%

Profitability Ratios

MDGS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -12.66% underscores its earnings before tax deductions. The effective tax rate stands at -2.11%, revealing its tax efficiency. The net income per EBT, 106.60%, and the EBT per EBIT, 146.51%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -8.64%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-12.66%
Effective Tax Rate-2.11%
Net Income per EBT106.60%
EBT per EBIT146.51%
EBIT per Revenue-8.64%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.30, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding122
Days of Inventory Outstanding8
Operating Cycle84.91
Days of Payables Outstanding58
Cash Conversion Cycle27
Receivables Turnover4.74
Payables Turnover6.33
Inventory Turnover46.26
Fixed Asset Turnover140.95
Asset Turnover1.62

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -4.67, and free cash flow per share, -5.75, depict cash generation on a per-share basis. The cash per share value, 8.95, showcases liquidity position. A payout ratio of -0.27 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, -0.06, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-4.67
Free Cash Flow per Share-5.75
Cash per Share8.95
Payout Ratio-0.27
Operating Cash Flow Sales Ratio-0.06
Free Cash Flow to Operating Cash Flow Ratio1.23
Cash Flow Coverage Ratio-0.66
Short Term Coverage Ratio-0.95
Capital Expenditure Coverage Ratio-4.31
Dividend Paid and Capex Coverage Ratio-1.12
Dividend Payout Ratio0.55

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 13.53%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.36, we discern the balance between debt and equity financing. The long-term debt to capitalization, 10.12%, and total debt to capitalization, 26.74%, ratios shed light on its capital structure. An interest coverage of -4.72 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio13.53%
Debt Equity Ratio0.36
Long Term Debt to Capitalization10.12%
Total Debt to Capitalization26.74%
Interest Coverage-4.72
Cash Flow to Debt Ratio-0.66
Company Equity Multiplier2.70

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 56.50, provides a glimpse into top-line earnings distributed across each share. Net income per share, -6.28, reflects the portion of profit attributed to each share. The book value per share, 24.08, represents the net asset value distributed per share, while the tangible book value per share, 14.66, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share56.50
Net Income Per Share-6.28
Book Value Per Share24.08
Tangible Book Value Per Share14.66
Shareholders Equity Per Share24.08
Interest Debt Per Share3.72
Capex Per Share-0.05

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 807.87%, indicates top-line expansion, while the gross profit growth, 201.02%, reveals profitability trends. EBIT growth, -68.18%, and operating income growth, -68.18%, offer insights into operational profitability progression. The net income growth, -352.30%, showcases bottom-line expansion, and the EPS growth, -4930.77%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth807.87%
Gross Profit Growth201.02%
EBIT Growth-68.18%
Operating Income Growth-68.18%
Net Income Growth-352.30%
EPS Growth-4930.77%
EPS Diluted Growth-4930.77%
Weighted Average Shares Growth-94.71%
Weighted Average Shares Diluted Growth-94.71%
Operating Cash Flow Growth-7.73%
Free Cash Flow Growth-6.29%
5-Year Revenue Growth per Share340.64%
3-Year Revenue Growth per Share107699.36%
5-Year Operating CF Growth per Share97.29%
3-Year Operating CF Growth per Share-572.38%
5-Year Net Income Growth per Share91.01%
3-Year Net Income Growth per Share-130.67%
5-Year Shareholders Equity Growth per Share-84.09%
3-Year Shareholders Equity Growth per Share1769.67%
Receivables Growth1392.13%
Inventory Growth45.97%
Asset Growth63.49%
Book Value per Share Growth1403.37%
Debt Growth527.17%
R&D Expense Growth364.40%
SGA Expenses Growth52.11%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -2,338,139.78, captures the company's total value, considering both debt and equity. Income quality, 0.56, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.15, gauges operational efficiency, while the research and development to revenue, 5.28%, highlights investment in innovation. The ratio of intangibles to total assets, 31.60%, indicates the value of non-physical assets, and capex to operating cash flow, 1.31%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value-2,338,139.78
Income Quality0.56
Sales General and Administrative to Revenue0.15
Research and Development to Revenue5.28%
Intangibles to Total Assets31.60%
Capex to Operating Cash Flow1.31%
Capex to Revenue-0.08%
Capex to Depreciation-2.29%
Stock-Based Compensation to Revenue0.86%
Graham Number58.32
Return on Tangible Assets-15.28%
Graham Net Net1.17
Working Capital14,631,000
Tangible Asset Value23,827,000
Net Current Asset Value9,296,000
Average Receivables13,461,500
Average Payables10,561,500
Average Inventory1,509,000
Days Sales Outstanding100
Days Payables Outstanding96
Days of Inventory On Hand8
ROIC-28.28%
ROE-0.26%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.12, and the price to book ratio, 0.12, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.03, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.48, and price to operating cash flows, -0.51, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.12
Price to Book Ratio0.12
Price to Sales Ratio0.03
Price Cash Flow Ratio-0.51
Enterprise Value Multiple-0.69
Price Fair Value0.12
Price to Operating Cash Flow Ratio-0.51
Price to Free Cash Flows Ratio-0.48
Price to Tangible Book Ratio0.19
Enterprise Value to Sales-0.03
Enterprise Value Over EBITDA0.20
EV to Operating Cash Flow0.41
Earnings Yield-134.46%
Free Cash Flow Yield-75.48%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Medigus Ltd. (MDGS) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.206 in 2024.

What is the ticker symbol of Medigus Ltd. stock?

The ticker symbol of Medigus Ltd. stock is MDGS.

What is company IPO date?

IPO date of Medigus Ltd. is 2015-08-05.

What is company current share price?

Current share price is 2.745 USD.

What is stock market cap today?

The market cap of stock today is 4670996.000.

What is PEG ratio in 2024?

The current -0.002 is -0.002 in 2024.

What is the number of employees in 2024?

In 2024 the company has 77.